Statistics
Publications
57
Citations
7.8K
H-Index
31
Active since
1992
Norbert Bräu is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, hepatitis, and viral hepatitis.
Publications per year
1992–2022
57
57
Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection
Nezam H. Afdhal, Stefan Zeuzem, Paul Y. Kwo et al. · New England Journal of Medicine · 2014 · 1.7K citations · Full text
Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia
Iván O. Rosas, Norbert Bräu, Michael R. Waters et al. · New England Journal of Medicine · 2021 · 1.1K citations · Full text
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection
Graham R. Foster, Nezam H. Afdhal, Stuart K. Roberts et al. · New England Journal of Medicine · 2015 · 845 citations · Full text
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1
Susanna Naggie, Curtis Cooper, Michael S. Saag et al. · New England Journal of Medicine · 2015 · 463 citations · Full text
Glecaprevir and Pibrentasvir in Patients with HCV and Severe Renal Impairment
Edward Gane, Eric Lawitz, David Pugatch et al. · New England Journal of Medicine · 2017 · 394 citations · Full text
Rows per page
1–5 of 57